CareFirst BlueCross BlueShield

📍 Baltimore, United States🗓 Founded 1934👥 6,681 employees💰 Last funded Nov 2020
Insurance🌐 carefirst.com
Website LinkedIn
CareFirst. It’s not just our name. It’s our promise. Over 3.5 million people trust us with their healthcare needs, and we take this responsibility seriously. Our vision for healthcare is clear. Quality care should be easy to afford, easy to use and available to everyone. And what we’re building for you is exactly what we expect for ourselves and those we love. Every day, we make a meaningful difference in the communities where we live and work. We solve real problems for the people we serve with equal parts empathy and urgency—simplifying the complex, delivering tailored solutions and stepping forward with new ideas. RECRUITMENT FRAUD NOTICE: CareFirst is aware of an increase in fraudulent job offers being made on behalf of our recruitment team. Legitimate CareFirst recruiters will always contact you from an email address ending in “@carefirst.com” and will never ask for a payment in exchange for a job opportunity or ask you to submit sensitive personal information via email, phone, or text. Independent licensee of BCBSA.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1934
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in CareFirst BlueCross BlueShield?
CareFirst BlueCross BlueShield has 1 investors on record on gritt.io.
When did CareFirst BlueCross BlueShield last raise funding?
The most recent investment in CareFirst BlueCross BlueShield recorded on gritt.io was in November 2020.
When was CareFirst BlueCross BlueShield founded?
CareFirst BlueCross BlueShield was founded in 1934.
What industry is CareFirst BlueCross BlueShield in?
CareFirst BlueCross BlueShield operates in Insurance. Find similar Insurance investors on gritt.io.
Where is CareFirst BlueCross BlueShield based?
CareFirst BlueCross BlueShield is headquartered in Baltimore, United States.